Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuhuang is a Traditional Chinese Medicine (TCM) preparation developed by the Longhua Hospital affiliated with the Shanghai University of Traditional Chinese Medicine. Primarily utilized in the field of proctology, it is indicated for the treatment of hemorrhoids, hemorrhoidal bleeding, and anal fissures, and is frequently used to promote postoperative wound healing. The formulation typically incorporates herbal components such as Rhubarb (Rheum palmatum), which provide anti-inflammatory, analgesic, and hemostatic properties. Fuhuang functions by modulating local inflammatory responses, reducing capillary permeability, and accelerating tissue regeneration at the site of application. It is officially registered as a hospital preparation (医院制剂) in China, allowing for its clinical use within the developing institution's healthcare system.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fuhuang.